Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 2007

View Archived Issues

Novel cPLA2alpha inhibiting activity reported for the immunosuppressant agent FTY-720

Guidelines devised for photodynamic therapy for nonmelanoma skin cancer

Thymosin beta 4 modulates NF-kB inflammatory signaling in corneal epithelium

Recent Banyu patent imparts novel analgesic agents

Recent patents report novel therapeutic agents for HIV infection

Clinical trial data reveal safety and efficacy of infliximab in psoriasis

GSK and XenoPort sign agreement for XP-13512

Wound healing-accelerating effects of estradiol to be studied in patients requiring skin grafting

GSK and Fabre-Kramer sign global agreement for gepirone ER

Plethora studies PSD-597 as analgesic therapy in urogynecological procedures

Corautus Genetics and VIA Pharmaceuticals to merge

Enrollment open in pilot venous leg ulcer study of Celaderm

Phase IIa study of LAB's GHRH completes enrollment

Critical Biologics closes Series A financing in support of rhu-pGSN development

First large-scale HIV trial begins in South Africa

Iclaprim safe in subjects with renal and hepatic impairment and obesity

Once-daily Xibrom formulation effective in treating postoperative ocular pain

Apotherapy CD40 research program receives E.U. funding

Ostabolin-C meets primary endpoint in phase II osteoporosis study

Low-dose interferon alpha lozenges studied for HIV patients with oral warts

ViaCell will not advance CB-001 based on phase I findings

Gilead and Achillion advance NS4A antagonist collaboration

Nuvo discusses Pennsaid approvable letter requirements with FDA

AGS-004 studied in phase I/II trial in HIV-infected adults

Guangdong Lantai Viewland to develop MIV-160 for China

Nexavar extends survival in advanced hepatocellular carcinoma

Recent patents describe new treatments for endocrine-related disorders

Danish approval for phase I study of novel anticoagulant TB-402

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...